Skip Navigation
Menu
Letters |15 November 2005

Sibutramine Use Associated with Reversible Hepatotoxicity

Athina Chounta, MD; Sotirios Tsiodras, MD; Spyros Zouridakis, MD; Michalis Doumas, MD; Helen Giamarellou, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From Attikon University Hospital, Xaipari, Greece 12462.

    Potential Financial Conflicts of Interest: None disclosed.

×
FULL TEXT
TO THE EDITOR:
Background: Obesity continues to be a major health problem in western nations (1) and in developing countries (2). Several prescription medications are used for weight loss, including the relatively new agent sibutramine (introduced in 1997). Sibutramine is a norepinephrine and serotonin reuptake inhibitor that may also stimulate thermogenesis. The drug is well tolerated, and most of the reported adverse events are mild or moderate in severity. In 2002, the Italian regulatory authority temporarily suspended market authorization, citing 50 adverse reactions (3). These reactions most frequently related to the cardiovascular system, including rapid heart rate, palpitations,...
FULL TEXT
PDF
Not Available
Citations
Citation

Chounta A, Tsiodras S, Zouridakis S, et al. Sibutramine Use Associated with Reversible Hepatotoxicity. Ann Intern Med. 2005;143:763–764. doi: 10.7326/0003-4819-143-10-200511150-00030

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2005;143(10):763-764.

DOI: 10.7326/0003-4819-143-10-200511150-00030

©
2005 American College of Physicians
10 Citations
CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×